Dual-Phase 18F-FDG PET in the Diagnosis of Pulmonary Nodules with an Initial Standard Uptake Value Less Than 2.5
- 1 August 2008
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 191 (2) , 475-479
- https://doi.org/10.2214/ajr.07.3457
Abstract
OBJECTIVE. A cutoff standard uptake value (SUV) of 2.5 has been commonly adopted for 18F-FDG PET to evaluate pulmonary lesions, but false results can occur. Studies have shown the usefulness of delayed PET for improving accuracy. This study was designed to examine the efficiency of delayed PET of pulmonary nodules with an initial mean SUV less than 2.5. MATERIALS AND METHODS. Dual-phase FDG PET studies were conducted with imaging 1 and 2 hours after FDG injection, and pulmonary lesions with an initial mean SUV less than 2.5 were identified. Nodules with pathologic reports were included in the study. The differences in mean SUV, maximal SUV, and retention index between benign and malignant pulmonary lesions were analyzed. Receiver operating characteristic analysis was performed to evaluate the discriminating validity of the retention index. RESULTS. A total of 31 lesions (15 benign, 16 malignant) were included in the study. Among the benign lesions, 12 were granulomatous inflammation, including 10 tuberculosis lesions and two cryptococcosis lesions, and three were focal fibrosis. A retention index greater than 0% was observed in 87% of the benign lesions; 60% of the benign lesions had a retention index greater than 10%. Among the malignant lesions, 75% had a retention index greater than 0%, and 62% had a retention index greater than 10%. We found no significant differences in mean SUV, maximal SUV, and retention index between benign and malignant lesions. The area under the receiver operating characteristic curve did not differ from 0.5. CONCLUSION. Delayed FDG PET is not useful for differentiating benign and malignant pulmonary nodules with an initial mean SUV less than 2.5 in geographic regions with epidemic granulomatous disease such as tuberculosis or in patients at high risk of granulomatous inflammation.Keywords
This publication has 21 references indexed in Scilit:
- Dual-Time Point FDG PET Imaging in the Evaluation of Pulmonary Nodules With Minimally Increased Metabolic ActivityClinical Nuclear Medicine, 2007
- Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?European Journal of Nuclear Medicine and Molecular Imaging, 2004
- Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT imagesLung Cancer, 2004
- Limitations of dual time point FDG-PET imaging in the evaluation of focal abdominal lesionsNuklearmedizin-Nuclear Medicine, 2004
- Advantage of delayed whole-body FDG-PET imaging for tumour detection.European Journal of Nuclear Medicine and Molecular Imaging, 2001
- Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass LesionsJAMA, 2001
- Pulmonary abnormalities and PET data analysis: a retrospective study.Radiology, 1997
- FDG-PET in infectious lesions: The detection and assessment of lesion activityAnnals of Nuclear Medicine, 1996
- Evaluation of Pulmonary Lesions With FDG-PETChest, 1996
- Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)The Journal of Thoracic and Cardiovascular Surgery, 1995